Dr. Todd Vincent Panarese, MD

Dr. Panarese practices at Cancer Care Centers of Brevard Inc in Merritt Island, Florida.

Dr. Panarese's NPI, 1427125053, was assigned on November 29, 2006. Dr. Panarese graduated from New York Medical College in 1989. Dr. Panarese holds Florida license ME 96595.

Dr. Panarese's primary practice is Cancer Care Centers of Brevard Inc, at 215 Cone Rd, Merritt Island, FL 32952 in Brevard County. The practice phone is (321) 952-0898.

Dr. Panarese's primary practice is Cancer Care Centers of Brevard Inc in Merritt Island, Florida. Dr. Panarese is also affiliated with Cape Canaveral Hospital. The medical group on file is Cancer Care Centers of Brevard. Dmand AI also links Dr. Panarese to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Panarese practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Panarese's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Panarese is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Panarese's licenses on file in 4 states: Florida, Texas, New Jersey and Pennsylvania.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Panarese treats.

CMS data shows 10,032 Medicare services from Dr. Panarese across 34 procedure codes in 2024, for 552 Medicare patients. Medicare paid $1,301,482 for them. Every service was in an office.

CMS counts 552 Medicare patients who saw Dr. Panarese in 2024. The largest group is 75 to 84, with 241 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Panarese's median patient age at 73, with 39% women.

In 2024, Dr. Panarese wrote 200 Medicare Part D claims for 94 patients. 97% of them were for generic drugs. CMS names the drug for 159 of them, across 3 drugs with 11 or more claims each, at $1,627 in total drug cost. In 2023, CMS named 134 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Panarese for performance year 2024, reported individually. Dr. Panarese accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 288 general payments to Dr. Panarese from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,290.

Dr. Panarese graduated from New York Medical College in 1989.

Dr. Panarese is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.